N-methylated β-carbolines protect PC12 cells from cytotoxic effect of MPP+ by attenuation of mitochondrial membrane permeability change

Neuroscience Research

Volumn 46, Issue 3, 2003, Pages 349-358

  Park, Tai Hwan ^a   Kwon, Oh Sang ^a   Park, Se Young ^a   Han, Eun Sook ^a   Lee, Chung Soo ^a  

^a Chung Ang University   (South Korea)

Author keywords

GSH depletion; Mitochondrial membrane permeability; MPP+; PC12 cells; Reactive oxygen species formation; Carbolines

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; BETA CARBOLINE DERIVATIVE; CASPASE 3; CATALASE; CYTOCHROME C; DITHIOTHREITOL; GLUTATHIONE; HARMALINE; HARMALOL; HYDROGEN PEROXIDE; LINSIDOMINE; METHYL 4 PHENYLPYRIDINIUM; PYRIDINIUM DERIVATIVE; REACTIVE OXYGEN METABOLITE; RUTOSIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATTENUATION; CELL DEATH; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FRAGMENTATION REACTION; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; METHYLATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

EID: 0038510883     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(03)00097-X     Document Type: Article

References (49)

1. Albores R., Neafsey E.J., Drucker G., Fields J.Z., Collins M.A. Mitochondrial respiratory inhibition by N-methylated β-carboline derivatives structurally resembling N-methyl-4-phenylpyridine. Proc. Natl. Acad. Sci. USA. 87:1990;9368-9372.
2. Amarante-Mendes G.P., Kim C.N., Liu L., Huang Y., Perkins C.L., Greeen D.R., Bhalla K. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockade of mitochondrial release of cytochrome c and activation of caspase-3. Blood. 91:1998;1700-1705.
3. Atlante A., Calissano P., Bobba A., Giannattasio S., Marra E., Passarella S. Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lett. 497:2001;1-5.
4. Banaclocha M.M., Hernandez A.I., Martinez N., Ferrandiz M.L. N-acetylcysteine protects against age-related increase in oxidized proteins in mouse synaptic mitochondria. Brain Res. 762:1997;256-258.
5. Bernardi P. The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim. Biophys. Acta. 1275:1996;5-9.
6. Birkmayer W., Knoll J., Riederer P., Youdim M.B., Hars V., Marton J. Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study. J. Neural Transm. 64:1985;113-127.
7. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta. 1453:1999;49-62.
8. Chakraborati T., Das S., Mondal M., Roychoudhury S., Chakraborti S. Oxidant, mitochondria and calcium: an overview. Cell. Signal. 11:1999;77-85.
9. Chandra J., Samali A., Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 29:2000;323-333.
10. + in PC12 cells: insights into potential neurotoxicants in Parkinson's disease. J. Neurochem. 62:1994;1503-1510.
11. Du Y., Dodel R.C., Bales K.R., Jemmerson R., Hamiton-Byrd E., Paul S.M. Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J. Neurochem. 69:1997;1382-1388.
12. Fernandez de Arriva A., Lizcano J.M., Balsa M.D., Unzeta M. Inhibition of monoamine oxidase from bovine retina by β-carbolines. J. Pharm. Pharmacol. 46:1994;809-813.
13. + and MPTP in PC12 cells independent of reactive oxygen species formation. Brain Res. 905:2001;199-206.
14. Fu W., Luo H., Parthasarathy S., Mattson M.P. Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol. Dis. 5:1998;229-243.
15. Fuller R., Wong C.J., Hemrick-Luecke S.K. MD240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice. Life Sci. 38:1986;409-412.
16. +. Neurosci. Res. 44:2002;255-265.
17. Halliwell B., Gutteridge J.M.C. Detection of free radicals and other reactive species: trapping and fingerprinting. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. third ed. 1999;351-429 Oxford University Press, New York.
18. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R.T., Beal M.F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2:1996;1017-1021.
19. Isenberg J.S., Klaunig J.E. Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells. Toxicol. Sci. 53:2000;340-351.
20. Jacobsson S.O., Fowler C.J. Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: effects of NMDA antagonists, antioxidants and MAO inhibitors. Neurochem. Int. 34:1999;49-62.
21. Jurma O.P., Hom D.G., Andersen J.K. Decreased glutathione results in calcium-mediated cell death in PC12. Free Radic. Biol. Med. 23:1997;1055-1066.
22. Kadota T., Yamaai T., Saito Y., Akita Y., Kawashima S., Moroi K., Inagaki N., Kadota K. Expression of dopamine transporter at the tips of growing neurites of PC12 cells. J. Histochem. Cytochem. 44:1996;989-996.
23. Kim D.H., Jang Y.Y., Han E.S., Lee C.S. Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells. Eur. J. Neurosci. 13:2001;1861-1872.
24. Kuhn W., Muller T., Grosse H., Rommelspacher H. Plasma harman and norharman in Parkinson's disease. J. Neural Transm. Suppl. 46:1995;291-295.
25. Lee C.S., Han E.S., Jang Y.Y., Han J.H., Ha H.W., Kim D.E. Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 Cells. J. Neurochem. 75:2000;521-531.
26. + on membrane permeability in brain mitochondria and cell viability in PC12 cells. Neurochem. Int. 40:2002;361-369.
27. Lizard G., Miguet C., Bessede G., Monier S., Gueldry S., Neel D., Gambert P. Impairment with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occurring during 7-ketocholesterol-induced apoptosis. Free Radic. Biol. Med. 28:2000;743-753.
28. Lotharius J., O'Malley K.L. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J. Biol. Chem. 275:2000;38581-38588.
29. Lotharius J., Dugan L.L., O'Malley K.L. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 19:1999;1284-1293.
30. Maher P., Davis J.B. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16:1996;6394-6401.
31. Matsubara K., Collins M.A., Akane A., Ikebuchi J., Neafsey E.J., Kagawa M., Shiono H. Potential bioactivated neurotoxicants, N-methylated β-carbolinium ions, are present in human brain. Brain Res. 610:1993;90-96.
32. + analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease. Neurology. 45:1995;2240-2245.
33. Matsubara K., Gonda T., Sawada H., Uezono T., Kobayashi Y., Kawamura T., Ohtaki K., Kimura K., Akaike A. Endogenously occurring β-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease. J. Neurochem. 70:1998;727-735.
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
35. Obata T. Dopamine efflux by MPTP and hydroxyl radical generation. J. Neural Transm. 109:2002;1159-1180.
36. +) into the striatum is associated with hydroxyl free radical generation. Brain Res. 906:2001;170-175.
37. Oberhammer F.A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A.F., Bursch W., Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA. 89:1992;5408-5412.
38. O'Hearn E., Molliver M.E. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience. 55:1993;303-310.
39. 2+ homeostasis. Neurosci. Res. 37:2000;227-236.
40. Prdzedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA. 93:1996;4565-4571.
41. Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268:1995;L699-L722.
42. + administration to mice. Pharamcol. Toxicol. 72:1993;364-368.
43. Seaton T.A., Cooper J.M., Schapira A.H. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res. 777:1997;110-118.
44. Tan S., Sagara Y., Liu Y., Maher P., Schubert D. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141:1998;1423-1432.
45. Tatton W.G., Chalmers-Redman R.M. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration. Neurology. 47:1996;S171-S183.
46. Tatton W.G., Chalmers-Redman R.M.E., Ju W.J.H., Mammen M., Carlile G.W., Pong A.W., Tatton N.A. Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J. Pharmacol. Exp. Ther. 301:2002;753-764.
47. van Klaveren R.J., Hoet P.H., Pype J.L., Demedts M., Nemery B. Increase in gamma-glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Radic. Biol. Med. 22:1997;525-534.
48. + toxicity in vivo. Ann. New York Acad. Sci. 899:2000;255-261.
49. Zeevalk G.D., Bernard L.P., Albers D.S., Mirochnitchenko O., Nicklas W.J., Sonsalla P.K. Energy stress-induced dopamine loss in glutathione peroxidase-overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures. J. Neurochem. 68:1997;426-429.